Wellington Partners logo

Wellington Partners

Europe, Bayern, Germany, Munich

Description

Wellington Partners is a venture capital firm that invests in technology and life sciences companies.

Investor Profile

Wellington Partners has made 244 investments, with 7 in the past 12 months and 31% as lead.

Stage Focus

  • Series A (30%)
  • Series B (22%)
  • Series Unknown (14%)
  • Series C (11%)
  • Seed (10%)
  • Series D (8%)
  • Series E (2%)
  • Private Equity (2%)
  • Post Ipo Equity (1%)

Country Focus

  • Germany (35%)
  • United States (20%)
  • United Kingdom (13%)
  • France (8%)
  • Switzerland (5%)
  • Sweden (5%)
  • Denmark (3%)
  • Finland (2%)
  • Austria (2%)
  • Belgium (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Software
  • Medical Device
  • Therapeutics
  • Mobile
  • Manufacturing
  • Information Technology
  • E-commerce
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Wellington Partners frequently co-invest with?

HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 8
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 7
Earlybird Venture Capital
Europe, Berlin, Germany, Berlin
Co-Investments: 8
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 9
b2venture
Europe, Berlin, Germany, Berlin
Co-Investments: 9
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 11
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 8
OpenOcean
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 7
Balderton Capital
Europe, England, United Kingdom, London
Co-Investments: 9
Auriga Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 7

Which angels does Wellington Partners often collaborate with?

BH
Europe, England, United Kingdom, London
Shared Deals: 2
DA
Europe, Windsor and Maidenhead, United Kingdom, Windsor
Shared Deals: 1
JY
North America, California, United States, San Francisco
Shared Deals: 2
EJ
Europe, Ile-de-France, France, Paris
Shared Deals: 2
SC
Europe, England, United Kingdom, London
Shared Deals: 2
AM
North America, California, United States, San Francisco
Shared Deals: 1
FN
North America, California, United States, Menlo Park
Shared Deals: 1
GK
North America, Nevada, United States, Crystal Bay
Shared Deals: 1
LM
North America, California, United States, Menlo Park
Shared Deals: 3
PR
Europe, England, United Kingdom, London
Shared Deals: 2

What are some of recent deals done by Wellington Partners?

Hilo

Neuchâtel, Neuchatel, Switzerland

Hilo is a healthcare company that provides blood pressure, digital therapeutics, and patient management services.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMedical DevicePersonal HealthWearables
Series BMay 1, 2025
Amount Raised: $42,000,000
HepaRegeniX

Ulm, Baden-Wurttemberg, Germany

HepaRegeniX is developing drugs for treating acute and chronic liver diseases.

BiotechnologyHealth CareLife ScienceTherapeutics
Series UnknownApr 15, 2025
Amount Raised: $24,347,460
Aignostics

Berlin, Berlin, Germany

Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMachine LearningSoftware
Series BOct 29, 2024
Amount Raised: $34,000,000
CorFlow Therapeutics

Baar, Zug, Switzerland

CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions.

BiotechnologyManufacturingMedicalMedical Device
Series BSep 10, 2024
Amount Raised: $48,489,444
Sphingotec GmbH

Hohen Neuendorf, Brandenburg, Germany

SphingoTec develops innovative biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions.

Biotechnology
Series CAug 8, 2024
Amount Raised: $5,469,089
Confo Therapeutics

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.

BiotechnologyHealth CareMedicalTherapeutics
Series BJul 26, 2024
Amount Raised: $65,148,419
SciRhom

Martinsried, Bayern, Germany

SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.

BiotechnologyHealth Care
Series AJul 9, 2024
Amount Raised: $68,190,674
UroMems

Grenoble, Rhone-Alpes, France

UroMems is an innovative medtech company.

Health CareMedicalMedical Device
Series CJun 25, 2024
Amount Raised: $47,233,106
Seamless Therapeutics

Dresden, Sachsen, Germany

Seamless Therapeutics is reshaping the gene editing paradigm with a novel approach to restoring health in patients.

GeneticsTherapeutics
SeedApr 23, 2024
Amount Raised: $12,628,776
Onward

Eindhoven, Noord-Brabant, The Netherlands

Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.

BiotechnologyHealth CareMachinery ManufacturingMedicalMedical DeviceTherapeutics
Post Ipo EquityMar 20, 2024
Amount Raised: $21,875,113